Foldable, REconfigurable & Jagged devices for enhanced drug Absorption/seeding

The project aims to develop Self-configurable, Proximity Enabling Devices (SPEDs) for efficient oral delivery of protein/peptide drugs by enhancing retention and interaction with the intestinal wall.

Subsidie
€ 2.556.251
2022

Projectdetails

Introduction

Oral delivery of protein/peptide drugs is extremely challenging, and the majority of research in the field is based on exploring new formulations, for instance, using permeation enhancers. In recent years, some research has been done on ingestible devices for internal injections.

Proposed Approach

Here, I propose an entirely new approach based on what we have named Self-configurable, Proximity Enabling Devices (SPEDs). The idea is that these devices (the simplest ones will be rolled-up foils) will unfold in the gut, embed in the mucus layer, and align to the intestinal wall.

Importance of Proximity

It is essential that the SPED has close proximity to the intestinal wall and is retained for a while in order to ensure efficient drug delivery. The proximity will additionally allow us to study and explore the influence of nanotextures (embedded in the SPED) on the interaction with the intestinal wall as well as micromotor-based delivery.

Specific Objectives

The SPEDs will be developed and characterized with the following specific objectives:

  1. Understanding the SPED properties needed to penetrate mucus.
  2. Investigating the mechanisms for enhanced retention time.
  3. Exploring the SPED as a carrier for self-propelling cargo.
  4. Unraveling the overall behavior of SPED.
  5. Demonstrating anti-diabetic drug formulation delivery with at least 5% systemic uptake and showing feasibility of a wider range of applications (delivering/seeding e.g., peptide and proteins/vaccines/probiotics).

Methodology

The work will include:

  • Simulations of soft materials.
  • Device design.
  • Micro/nano fabrication.
  • Development and use of techniques for mechanical characterization of device/tissue interaction.
  • Bioimaging and in vitro and in vivo studies.

Novelty

The major novelty lies in the SPED concept, providing tissue alignment/contact and unidirectional drug release. Further, the SPEDs provide a unique platform for studies on micromotors as well as nanotextures interaction with the epithelium.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.556.251
Totale projectbegroting€ 2.556.251

Tijdlijn

Startdatum1-10-2022
Einddatum30-9-2027
Subsidiejaar2022

Partners & Locaties

Projectpartners

  • DANMARKS TEKNISKE UNIVERSITETpenvoerder

Land(en)

Denmark

Vergelijkbare projecten binnen European Research Council

ERC Starting...

Multifunctional Platform Technology for Magnetically Actuated Controlled Drug Release from Biodegradable Scaffolds

MAD Control aims to develop a multifunctional platform for biodegradable cardiovascular scaffolds that enables precise, on-demand drug release through real-time imaging and magnetic actuation.

€ 1.495.288
ERC Proof of...

Modification of liposomic nano-carriers: a novel strategy for improved drug-delivery and eradication of bacterial biofilms

This project aims to develop and evaluate a novel drug delivery system to effectively treat and eradicate bacterial biofilms, addressing significant health and economic challenges.

€ 150.000
ERC Starting...

Wireless magnetothermal entero-modulation

This project aims to develop a biocompatible magnetic gel for remote activation of intestinal tissue to modulate calcium signaling and neuropeptide release, addressing GI disorders non-invasively.

€ 1.500.000
ERC Proof of...

Mix and Match: One-step activation for targeted drug delivery

This project aims to develop a novel, efficient method for on-demand attachment of targeting ligands to nanocarriers, enhancing drug delivery efficacy while reducing toxicity in cancer therapies.

€ 150.000
ERC Consolid...

Nanostructure formation during food protein digestion and influence on intestinal transport

PRODIGEST aims to enhance sustainable food production by investigating the structural and mechanistic aspects of protein digestion to improve nutrient bioavailability and health outcomes.

€ 2.355.741

Vergelijkbare projecten uit andere regelingen

EIC Pathfinder

Personalised Adaptive Medicine

The PERAMEDIC project aims to develop a desktop-sized system for personalized polypill formulation using 3D printing and precise dosing to enhance treatment outcomes and patient adherence.

€ 1.726.876
EIC Pathfinder

INTELLIGENT ENCAPSULATION AND SCREENING PLATFORM FOR PRECISION DELIVERY OF PROBIOTICS TO IMPROVE GUT HEALTH

iNSIGHT aims to develop precision probiotics through innovative microencapsulation for targeted delivery, enhancing gut health and addressing related diseases using advanced technology and personalized treatment.

€ 3.194.343
EIC Pathfinder

ISOS-Implantable Ecosystems of Genetically Modified Bacteria for the Personalized Treatment of Patients with Chronic Diseases

ISOS aims to create a personalized bioreactor using engineered probiotics for on-demand delivery of therapeutic compounds to treat chronic diseases like age-related macular degeneration.

€ 2.433.300
EIC Pathfinder

SKIN MICROBIAL DEVICES

SKINDEV aims to develop Smart Skin Microbial Devices for non-invasive monitoring and treatment of atopic dermatitis through innovative sensing technologies and genetic engineering.

€ 1.718.408
EIC Pathfinder

On-Demand Bioresorbable OptoElectronic System for In-Vivo and In-Situ Monitoring of Chemotherapeutic Drugs

Develop a bioresorbable chemical sensing system for real-time monitoring of doxorubicin in-vivo, enhancing personalized cancer treatment while eliminating the need for device retrieval surgery.

€ 2.606.250